Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1017185.RA5c6GhsKCeMZ0p_JN0CAhUHQ6ufh2mFaesVq2cLwsRDA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1017185.RA5c6GhsKCeMZ0p_JN0CAhUHQ6ufh2mFaesVq2cLwsRDA130_assertion type Assertion NP1017185.RA5c6GhsKCeMZ0p_JN0CAhUHQ6ufh2mFaesVq2cLwsRDA130_head.
- NP1017185.RA5c6GhsKCeMZ0p_JN0CAhUHQ6ufh2mFaesVq2cLwsRDA130_assertion description "[We tested a panel of markers composed of the anti-apoptotic protein FLIP and its transcriptional regulators Sp1 and Sp3 using prostate tissues from 64 patients with recurrent and non-recurrent cancer who underwent radical prostatectomy as primary treatment for prostate cancer and were followed with PSA measurements for at least 5 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1017185.RA5c6GhsKCeMZ0p_JN0CAhUHQ6ufh2mFaesVq2cLwsRDA130_provenance.
- NP1017185.RA5c6GhsKCeMZ0p_JN0CAhUHQ6ufh2mFaesVq2cLwsRDA130_assertion evidence source_evidence_literature NP1017185.RA5c6GhsKCeMZ0p_JN0CAhUHQ6ufh2mFaesVq2cLwsRDA130_provenance.
- NP1017185.RA5c6GhsKCeMZ0p_JN0CAhUHQ6ufh2mFaesVq2cLwsRDA130_assertion SIO_000772 23028678 NP1017185.RA5c6GhsKCeMZ0p_JN0CAhUHQ6ufh2mFaesVq2cLwsRDA130_provenance.
- NP1017185.RA5c6GhsKCeMZ0p_JN0CAhUHQ6ufh2mFaesVq2cLwsRDA130_assertion wasDerivedFrom befree-2016 NP1017185.RA5c6GhsKCeMZ0p_JN0CAhUHQ6ufh2mFaesVq2cLwsRDA130_provenance.
- NP1017185.RA5c6GhsKCeMZ0p_JN0CAhUHQ6ufh2mFaesVq2cLwsRDA130_assertion wasGeneratedBy ECO_0000203 NP1017185.RA5c6GhsKCeMZ0p_JN0CAhUHQ6ufh2mFaesVq2cLwsRDA130_provenance.